DE69126437D1 - Inhibitor der blutplättchen-aggregation - Google Patents

Inhibitor der blutplättchen-aggregation

Info

Publication number
DE69126437D1
DE69126437D1 DE69126437T DE69126437T DE69126437D1 DE 69126437 D1 DE69126437 D1 DE 69126437D1 DE 69126437 T DE69126437 T DE 69126437T DE 69126437 T DE69126437 T DE 69126437T DE 69126437 D1 DE69126437 D1 DE 69126437D1
Authority
DE
Germany
Prior art keywords
pct
date apr
sec
aggregation inhibitor
leech
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69126437T
Other languages
English (en)
Other versions
DE69126437T2 (de
Inventor
Roy T Sawyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of DE69126437D1 publication Critical patent/DE69126437D1/de
Application granted granted Critical
Publication of DE69126437T2 publication Critical patent/DE69126437T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DE69126437T 1990-10-10 1991-10-10 Inhibitor der blutplättchen-aggregation Expired - Lifetime DE69126437T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909022040A GB9022040D0 (en) 1990-10-10 1990-10-10 Platelet adhesion inhibitor
PCT/GB1991/001763 WO1992007005A1 (en) 1990-10-10 1991-10-10 Platelet adhesion inhibitor

Publications (2)

Publication Number Publication Date
DE69126437D1 true DE69126437D1 (de) 1997-07-10
DE69126437T2 DE69126437T2 (de) 1997-12-04

Family

ID=10683506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69126437T Expired - Lifetime DE69126437T2 (de) 1990-10-10 1991-10-10 Inhibitor der blutplättchen-aggregation

Country Status (12)

Country Link
US (1) US5587360A (de)
EP (1) EP0552269B1 (de)
JP (1) JP3558292B2 (de)
AT (1) ATE154034T1 (de)
AU (1) AU659807B2 (de)
CA (1) CA2093819C (de)
DE (1) DE69126437T2 (de)
DK (1) DK0552269T3 (de)
ES (1) ES2103831T3 (de)
GB (1) GB9022040D0 (de)
GR (1) GR3024437T3 (de)
WO (1) WO1992007005A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT662088E (pt) * 1993-07-01 2002-06-28 Merck Patent Gmbh Inibidor da agregacao de plaquetas estimulada por colagenio
ES2153760B1 (es) * 1998-11-25 2001-07-01 Univ Barcelona Autonoma Inhibidor de metalocarboxipeptidasas como agente fibrinolitico.
EP1161530B1 (de) * 1999-03-18 2005-05-18 MERCK PATENT GmbH Plättchenadhäsion blockierendes protein
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
US7691839B2 (en) 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
EP2316465A1 (de) * 2009-10-15 2011-05-04 Centre National De La Recherche Scientifique Verwendung von Extrakt von Blutegelspeichel als antibakterielles Mittel zur Herstellung unterschiedlicher Zusammensetzungen
ES2610556T3 (es) 2011-01-31 2017-04-28 Council Of Scientific & Industrial Research 1-(4-metilfenilmetil)-5-oxo-{N-[(3-t-butoxicarbonil-aminometil)]-piperidin-1-il}-pirrolidin-2-carboxamidas quirales como inhibidores de la activación y adhesión de plaquetas inducidas por colágeno
CN107287269A (zh) * 2017-06-19 2017-10-24 山东大学 一种减轻水蛭出血不良反应的水蛭肽制备工艺
EP3870598A1 (de) 2018-10-23 2021-09-01 Dragonfly Therapeutics, Inc. Heterodimere fc-kondensierte proteine
IL297495A (en) 2020-04-22 2022-12-01 Dragonfly Therapeutics Inc Dosing regimen, formulation and manufacturing process for fc fusion heterodimeric proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
US4588587A (en) * 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
US5139944A (en) * 1985-08-10 1992-08-18 Biophram (Uk) Limited Collagen-specific enzyme with platelet aggregation inhibition properties
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US4832849A (en) * 1988-06-16 1989-05-23 Merrell Dow Pharmaceuticals Inc. Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
IL86857A (en) * 1988-06-24 1994-04-12 Yissum Res Dev Co Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same

Also Published As

Publication number Publication date
CA2093819C (en) 2002-04-30
DK0552269T3 (da) 1997-11-03
EP0552269B1 (de) 1997-06-04
JP3558292B2 (ja) 2004-08-25
ES2103831T3 (es) 1997-10-01
DE69126437T2 (de) 1997-12-04
GB9022040D0 (en) 1990-11-21
AU659807B2 (en) 1995-06-01
JPH06505703A (ja) 1994-06-30
ATE154034T1 (de) 1997-06-15
CA2093819A1 (en) 1992-04-11
AU8666691A (en) 1992-05-20
WO1992007005A1 (en) 1992-04-30
US5587360A (en) 1996-12-24
EP0552269A1 (de) 1993-07-28
GR3024437T3 (en) 1997-11-28

Similar Documents

Publication Publication Date Title
DE69126437D1 (de) Inhibitor der blutplättchen-aggregation
Dabb et al. The use of medicinal leeches in the salvage of flaps with venous congestion
DE69433356D1 (de) An der oberfläche modifizierte, biocompatible membranen
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
FR2678624B1 (de)
SE9103701D0 (sv) Apolipoprotein
EP0713493A4 (de) Produktion von menschlichem hämoglobin in transgenen schweinen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ATE156664T1 (de) Mittel zur steigerung der haltbarkeit von schlachttierkörpern
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
UA41332C2 (uk) Білок, здатний інгібувати стимульовану колагеном агрегацію тромбоцитів, спосіб його одержання, фармацевтичний препарат, спосіб обробки імплантованого або екстракорпорального медичного пристрою та спосіб одержання лікарського засобу
GB9411009D0 (en) Dialysis fluid
ATE190839T1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
ATE227557T1 (de) Verwendung von zahnpflegemitteln enthaltend bovines kolostrum
BR9407669A (pt) Bandagem de ferida que compreende alginato
EP0898895A3 (de) Pökel zur Fleischverarbeitung
GEP20032966B (en) Ophthalmic Solution Comprising Glycogen
ES2097931T3 (es) Nueva proteina inhibidora de trombina a partir de chinches cazadoras.
ATE58460T1 (de) Nahrungsmittel auf der basis von schaffleisch.
Sawyer Platelet adhesion inhibitor
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung
DK0609242T3 (da) Nyt thrombininhibitorisk protein fra blodmider
ATE231001T1 (de) Verwendung von protein c inhibitor zur behandlung disseminierter intravasaler gerinnung (dic)
DE68908958D1 (de) Peptide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition